Latest News

2011 FDA safety message tied to drop in transvaginal mesh use

(HealthDay)—A 2011 U.S. Food and Drug Administration safety communication correlated with a significant decline in transvaginal mesh use for treatment of apical prolapse, according to a study published online Sept. 10 in Obstetrics & Gynecology.

Source link

Related posts

Woman's risk for negative mood, executive dysfunction after ovary removal linked to childhood adversity


Recovery after stroke: not so proportional after all?


AblaCare annonce un financement série A de 10 M€ mené par Sofinnova Partners pour développer un traitement contre l’infertilité et nomme Jodie Fam en tant que PDG


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy